Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2013 May 16;12(8):1638–1650. doi: 10.1158/1535-7163.MCT-13-0047

TABLE 1.

Relative Binding Affinity of C/EBP Isoforms at Candidate Consensus Sites in the Murine CPO Upstream Gene

Site Name Location of Site (nt) (a) Relative Affinity of Binding to Individual Isoforms (%)(b) Characteristics of the Binding Site
C/EBPα C/EBPβ (LAP) C/EBPβ (LIP) C/EBPβ (LAP*) C/EBPδ Mean Relative Affinity (%) (c) Isoform Score (d) Strength Category (e)
C1 −339 1.1 3.8 3.4 0.0 1.9 2.0% 4 Moderate
C2 −362 0.0 0.3 0.3 0.0 0.0 0.1% 2 Weak
C3 −483 9.5 7.7 10.4 0.0 4.0 6.3% 4 Moderate
C4 −570 0.5 0.8 2.6 0.0 0.0 0.8% 3 Weak
C5 −631 0.0 0.0 0.0 0.0 0.0 0.0% 0 No binding
C6 −647 34.4 32.2 26.6 70.8 35.5 39.9% 5 Strong
C7 −754 25.4 18.4 15.0 11.4 18.9 17.8% 5 Strong
C8 −836 23.4 15.4 14.8 10.4 18.2 16.5% 5 Strong
C9 −910 0.0 0.0 0.0 0.0 0.0 0.0% 0 No binding
C10 −930 0.9 3.6 5.7 3.1 3.8 3.4% 5 Moderate
C11 −1018 0.0 3.2 2.2 3.3 5.8 2.9% 4 Moderate
C12 −1027 1.1 3.9 3.0 0.9 5.9 3.0% 5 Moderate
C13 −1096 0.0 0.4 0.0 0.0 1.0 0.3% 2 Weak
C14 −1152 0.0 1.1 2.2 0.0 0.0 0.7% 2 Weak
C15 −1177 0.0 1.3 2.2 0.0 0.0 0.7% 2 Weak
C16 −1220 3.5 6.7 8.0 0.0 3.8 4.4% 4 Moderate
C17 −1297 0.2 1.1 3.7 0.0 1.2 1.2% 4 Weak
Total signal in binding assay: 100.0 100.0 100.0 100.0 100.0
(a)

Location upstream of ATG in the mCPO promoter. The nucleotide shown is +1 in each 10 bp C/EBP-binding motif as defined in Figure 4.

(b)

For each C/EBP protein isoform, binding affinities were estimated from the signal intensity of specific bands on EMSA autoradiograms. (Nuclear proteins from C/EBP-transfected COS-7 cells were bound to individual oligonucleotide probes encompassing each CPO promoter site). For each band, relative affinity was expressed as a percentage of the total signal intensity for that isoform, summed from all 17 promoter sites.

(c)

Mean binding affinity, averaged across all five C/EBP isoforms.

(d)

Isoform binding score: Number of C/EBP isoforms that showed detectable binding to that particular DNA sequence.

(e)

Binding Strength Category of the nucleotide sequence, defined as follows:

Strong: Mean binding affinity is > 10%; the site can bind to all five C/EBP isoforms.
Moderate: Mean binding affinity is at least 2%; the site can bind to 4 or more isoforms.
Weak: Mean binding affinity is less than 2%; the site can bind to at least 2 isoforms.
Non-binding The site fails to bind to any of the C/EBP isoforms.